Efficacy and Safety of Intranasal Morphine for Pain After Elective Orthopedic Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Pain, Postoperative
Interventions
DRUG

Intranasal Morphine

MNS075 7.5mg q1h PRN

DRUG

Placebo

IN Placebo q1h PRN

DRUG

IV morphine

IV morphine 7.5mg q3h PRN

DRUG

Placebo

IV Placebo q3h PRN

DRUG

Intranasal morphine

MNS075 15mg q3h PRN

DRUG

Placebo

IN Placebo q3h PRN

Trial Locations (7)

16801

University Orthopedics Center, State College

78666

SCIREX Corporation, San Marcos

78705

SCIREX Corporation, Austin

84124

Jean Brown Research, Salt Lake City

85023

Arizona Research Center, Phoenix

85050

HOPE Research Institute, Phoenix

93311

Vertex Clinical Research, Bakersfield

Sponsors
All Listed Sponsors
lead

Javelin Pharmaceuticals

INDUSTRY